Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Construction in Progress (2019 - 2020)

Historic Construction in Progress for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Q4 2020 value amounting to $20.4 million.

  • Maravai Lifesciences Holdings' Construction in Progress rose 17581.21% to $20.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $20.4 million, marking a year-over-year increase of 17581.21%. This contributed to the annual value of $20.4 million for FY2020, which is 17581.21% up from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Construction in Progress of $20.4 million as of Q4 2020, which was up 17581.21% from $7.4 million recorded in Q4 2019.
  • Maravai Lifesciences Holdings' Construction in Progress' 5-year high stood at $20.4 million during Q4 2020, with a 5-year trough of $7.4 million in Q4 2019.